C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Blue Water Vaccines Announces Sponsored Research Agreement Amendment to Continue Funding Universal Influenza Vaccine Development at The University of Oxford

Tuesday, May 31, 2022

Blue Water Vaccines Inc a biopharmaceutical company developing transformational vaccines to address significant global health challenges today announced the signing of an amendment to its existing Sponsored Research Agreement with The University of O...

Launch of DYSVAL® capsules 40mg for Treatment of Tardive Dyskinesia in Japan

Tuesday, May 31, 2022

Mitsubishi Tanabe Pharma Corporation Head Office Chuoku Osaka Representative Director Hiroaki Ueno hereinafter MTPC a member of the Mitsubishi Chemical Holdings Group announced today that MTPC is launching DYSVAL capsules mg generic name valbenazine...

Regeneron Completes Acquisition of Checkmate Pharmaceuticals

Tuesday, May 31, 2022

Regeneron Pharmaceuticals Inc announced that it has successfully acquired Checkmate Pharmaceuticals Inc deepening its commitment to immunooncology and adding a new modality to the companys portfolio of potential combinationready approaches for diffic...

Evotec adds cell therapy manufacturing facility with acquisition of Rigenerand

Monday, May 30, 2022

Evotec SE today announced the signing of a definitive agreement under which Evotec will acquire of the capital of Rigenerand Srl a leading cell technology company for a purchase price of m Founded in as a spinoff of the University of Modena and R...

CareRx Completes Acquisition of Hogan Long-Term Care Pharmacy

Monday, May 30, 2022

CareRx Corporation Canadas leading provider of pharmacy services to seniors living and other congregate care communities announced today it has closed the previously announced acquisition of Hogan Pharmacy Partners Ltd Hogan a longterm care pharmacy...

DuPont Opens New Biopharma Tubing Manufacturing Site in the United States

Tuesday, May 31, 2022

DuPont announced the opening of its new DuPont Liveo Healthcare manufacturing site in Cooper River South Carolina to help better serve customers worldwide The site located in Berkeley County will be operated using the same quality standards as DuPont...

Perrigo Announces U.S. FDA Approval For Omeprazole Magnesium Delayed-Release Mini Capsules

Thursday, May 26, 2022

Perrigo Company plc a leading provider of Consumer SelfCare Products today announced that it has received final approval from the US Food and Drug Administration for Omeprazole Magnesium DelayedRelease Mini Capsules mg overthecounter OTC Perrigo exp...

Sun Pharma Acquires UractivTM Portfolio from Fiterman Pharma in Romania

Thursday, May 26, 2022

Sun Pharma ceutical Industries Limited today a nnounced that one of its subsidiaries SC Terapia SA Romania has acquired the Uractiv TM portfolio from Fiterman Pharma in Romania The UractivTM portfolio comprises food supplements including minerals vit...

EugiaPharma receives USFDA Approval for Pemetrexed for Injection

Thursday, May 26, 2022

Aurobindo Pharma Limited is pleased to announce that its wholly owned subsidiary company Eugia Pharma Specialties Limited has received a final approval from the US Food Drug Administration USFDA to manufacture and market Pemetrexed for Injection mg...

Data from SOTIO’s Phase 1/1b AURELIO-03 Trial of SOT101 Demonstrate Clinical Benefit in Patients with Solid Tumors

Thursday, May 26, 2022

SOTIO Biotech a clinical stage immunooncology company owned by PPF Group announces updated interim safety and efficacy data from its Phase b AURELIO dose escalation study of the ILIL receptor superagonist SOT as monotherapy and in combination with p...